577 related articles for article (PubMed ID: 19162547)
1. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress.
Cugno M; Zanichelli A; Foieni F; Caccia S; Cicardi M
Trends Mol Med; 2009 Feb; 15(2):69-78. PubMed ID: 19162547
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
Castelli R; Zanichelli A; Cugno M
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):181-90. PubMed ID: 23137231
[TBL] [Abstract][Full Text] [Related]
3. Novel therapies for hereditary angioedema.
Zuraw BL
Immunol Allergy Clin North Am; 2006 Nov; 26(4):691-708. PubMed ID: 17085285
[TBL] [Abstract][Full Text] [Related]
4. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of angioedema in first complement component inhibitor deficiency.
Davis AE
Immunol Allergy Clin North Am; 2006 Nov; 26(4):633-51. PubMed ID: 17085282
[TBL] [Abstract][Full Text] [Related]
6. The plasma bradykinin-forming pathways and its interrelationships with complement.
Kaplan AP; Ghebrehiwet B
Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
[TBL] [Abstract][Full Text] [Related]
7. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation.
Cugno M; Castelli R; Cicardi M
Autoimmun Rev; 2008 Dec; 8(2):156-9. PubMed ID: 19014872
[TBL] [Abstract][Full Text] [Related]
8. Nonallergic angioedema: role of bradykinin.
Bas M; Adams V; Suvorava T; Niehues T; Hoffmann TK; Kojda G
Allergy; 2007 Aug; 62(8):842-56. PubMed ID: 17620062
[TBL] [Abstract][Full Text] [Related]
9. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
Joseph K; Tholanikunnel TE; Kaplan AP
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
[TBL] [Abstract][Full Text] [Related]
10. The pathogenesis of hereditary angioedema.
Davis AE
Transfus Apher Sci; 2003 Dec; 29(3):195-203. PubMed ID: 14572810
[TBL] [Abstract][Full Text] [Related]
11. The bradykinin-forming cascade and its role in hereditary angioedema.
Kaplan AP; Joseph K
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):193-204. PubMed ID: 20377108
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients.
Farkas H
Paediatr Drugs; 2018 Apr; 20(2):135-151. PubMed ID: 29214395
[TBL] [Abstract][Full Text] [Related]
13. The pathophysiology of hereditary angioedema.
Davis AE
Clin Immunol; 2005 Jan; 114(1):3-9. PubMed ID: 15596403
[TBL] [Abstract][Full Text] [Related]
14. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
[TBL] [Abstract][Full Text] [Related]
15. HAE Pathophysiology and Underlying Mechanisms.
Zuraw BL; Christiansen SC
Clin Rev Allergy Immunol; 2016 Oct; 51(2):216-29. PubMed ID: 27459852
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the management of hereditary angioedema.
Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
[TBL] [Abstract][Full Text] [Related]
17. Hereditary and acquired complement component 1 esterase inhibitor deficiency: a review for the hematologist.
Cicardi M; Johnston DT
Acta Haematol; 2012; 127(4):208-20. PubMed ID: 22456031
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin-mediated diseases.
Kaplan AP
Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
[TBL] [Abstract][Full Text] [Related]
19. An evidence based therapeutic approach to hereditary and acquired angioedema.
Bork K
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
[TBL] [Abstract][Full Text] [Related]
20. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations.
Bork K
Immunol Allergy Clin North Am; 2006 Nov; 26(4):709-24. PubMed ID: 17085286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
